Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

African trypanosomiasis (AT), also known as sleeping sickness in humans and Nagana in animals, is a disease caused by the protozoan parasite Trypanosoma brucei. AT is an extremely debilitating disease in human, cattle, and wild animals, and the treatment is difficult with frequent relapses. This work shows that BALB-c mice immunized intramuscularly with a single dose (100 mu g) of a plasmid DNA encoding the 5'-terminal region of the trans-sialidase (nTSA) gene of T. brucei brucei are able to produce IgG antibodies that bind to the bloodstream form of T. brucei-protein extract and recognize the recombinant nTSA protein, expressed in Escherichia coli. Furthermore, this DNA vaccination process was able to protect 60% of mice submitted to a challenge assay with the infective form of T. brucei brucei parasites. These results demonstrate that a DNA vaccine coding for trans-sialidase from T. brucei is potentially useful in the prophylaxis of AT.
Original languageUnknown
Pages (from-to)1223-1229
JournalParasitology Research
Volume105
Issue number5
DOIs
Publication statusPublished - 1 Jan 2009

Cite this